|
GnRH antagonist Clinical Trials
3 actively recruiting trials across 2 locations
▲ +1 trial since July 2026
Also known as: Degarelix Acetate
Pipeline
Phase 1: 1Phase 4: 1Phase 2/3: 1
Top Sponsors
- Xiaojun Chen1
- University of Colorado, Denver1
- Amgen1
Indications
- Cancer2
- Obesity, Abdominal1
- Progesterone Resistance1
- Atypical Endometrial Hyperplasia1
- Weight Loss1
Other1 trial
San Francisco, California1 trial
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
University of California San Francisco
Phase 1
Aurora, Colorado1 trial
Bioenergetic Effects of Aging and Menopause (BEAM)
University of Colorado - Anschutz Medical Campus
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.